代谢
这项研究旨在体外研究人肝制剂中alpha-侧柏酮的代谢特性,并确定细胞色素P450(CYP)以及可能的其他催化alpha-侧柏酮生物转化的酶的作用。通过开发一种液相色谱-质谱(LC-MS)方法来测量alpha-侧柏酮和四种潜在代谢物,实验结果表明人肝微粒体产生了两种主要代谢物(7-羟基侧柏酮和4-羟基侧柏酮)和两种次要代谢物(2-羟基侧柏酮和香荆芥酚)。在人肝匀浆中检测到了谷胱甘肽和半胱氨酸结合物,但未进行量化。没有检测到葡萄糖醛酸或硫酸结合物。主要羟基化反应占到了alpha-侧柏酮初级微粒体代谢的90%以上。通过CYP重组酶筛选alpha-侧柏酮的代谢,发现CYP2A6主要负责主要的7-和4-羟基化反应,尽管CYP3A4和CYP2B6参与程度较低,CYP3A4和CYP2B6催化了次要的2-羟基化反应。根据不同重组CYP酶的固有效率和这些酶在人肝微粒体中的平均丰度,计算出CYP2A6是人肝微粒体中最活跃的酶,平均负责70-80%的代谢。抑制作用筛选表明,alpha-侧柏酮抑制了CYP2A6和CYP2B6,50%抑制浓度值分别为15.4和17.5微摩尔。
This study aims to characterize the metabolism of alpha-thujone in human liver preparations in vitro and to identify the role of cytochrome P450 (CYP) and possibly other enzymes catalyzing alpha-thujone biotransformations. With a liquid chromatography-mass spectrometry (LC-MS) method developed for measuring alpha-thujone and four potential metabolites, it was demonstrated that human liver microsomes produced two major (7- and 4-hydroxy-thujone) and two minor (2-hydroxy-thujone and carvacrol) metabolites. Glutathione and cysteine conjugates were detected in human liver homogenates, but not quantified. No glucuronide or sulphate conjugates were detected. Major hydroxylations accounted for more than 90% of the primary microsomal metabolism of alpha-thujone. Screening of alpha-thujone metabolism with CYP recombinant enzymes indicated that CYP2A6 was principally responsible for the major 7- and 4-hydroxylation reactions, although CYP3A4 and CYP2B6 participated to a lesser extent and CYP3A4 and CYP2B6 catalyzed minor 2-hydroxylation. Based on the intrinsic efficiencies of different recombinant CYP enzymes and average abundances of these enzymes in human liver microsomes, CYP2A6 was calculated to be the most active enzyme in human liver microsomes, responsible for 70-80% of the metabolism on average. Inhibition screening indicated that alpha-thujone inhibited both CYP2A6 and CYP2B6, with 50% inhibitory concentration values of 15.4 and 17.5 uM, respectively.
来源:Hazardous Substances Data Bank (HSDB)